In recent years, with the continuous innovation and breakthrough in digital technology, artificial intelligence (AI) has also been applied to medical tests. On October 24th, Taiwan Lung Cancer Society, V5 TECHNOLOGIES, Intel Corp, and World Peace Industrial Group jointly organized the “Lung Cancer Diagnosis and Treatment and AI Application Seminar”. Experts and scholars, including Yuh-Min Chen (President of Taiwan Lung Cancer Society), Wan Yuo Guo (Chief of Department of Radiology, Taipei Veterans General Hospital), Dr. Quincy Lin (Chairman of V5 TECHNOLOGIES), Yu-Te Wu (Director of R&D, National Yang-Ming University), Der-Ming Liou (Director of Graduate Institute of Biomedical Informatics, Taipei Medical University), discussed the application of AI technology to medical tests presently from the perspectives of clinical practice, academics, and AI technology development.
In the seminar, Wan Yuo Guo (Chief of Department of Radiology, Taipei Veterans General Hospital) first presented the AI research on cancer spreading from lungs to brain, and in the second session Dr. Zhao Hengsheng (Taipei Veterans General Hospital) talked about the prospects of AI applications in clinical medicine. In the third session, Yu-Te Wu (Director of R&D, National Yang-Ming University) presented the “Lung Cancer X-ray Image Analysis AI System”. In the last session Tzu-Kuei Shen (Director of V5 TECHNOLOGIES) and Dr. Heng-Shengl Zhao (Taipei Veterans General Hospital) jointly presented “Computerized Tomography AI Analysis System for Lung Nodules and Clinical Application”. The AI system stresses the use of AI models and information sharing platforms to assist specialty doctors in accelerating the interpretation of small lung nodules and reducing errors. Since this is the first domestic academic seminar dedicated to lung cancer and artificial intelligence, it has received great attention and response.